From The Industry Experts
-
Could Moving To This Swiss Life Sciences Hub Be In Your Company's Future?
1/15/2026
Basel Area Business & Innovation CEO Christof Klöpper discusses how the Basel Area Life Sciences Supercluster supports discovery through commercialization.
-
Empower Your Trial With Data And Evidence
1/14/2026
Fuel your clinical development and decision-making with insights from fit-for-purpose data and evidence.
-
No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure
1/14/2026
This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.
-
Transforming PAH Trials For Patient-Centric Care
1/14/2026
PAH trials need patient-focused strategies. See how innovative designs, digital tools, and real-world data can simplify recruitment, reduce complexity, and improve outcomes in this challenging space.
-
Eligibility Criteria For Successful Retinal Study Delivery
1/14/2026
Clear eligibility criteria drive retinal trial success. Explore how strategic design improves recruitment, safeguards data integrity, and meets compliance for studies on complex ocular conditions.
-
Leading With Purpose: Meg Hooton's Global Journey in Biotech
1/14/2026
Biotech leadership requires vision, adaptability, and purpose. Aligning values with strategy and fostering collaboration empowers teams and drives innovation in a rapidly evolving industry.
-
Rethinking Alzheimer's Trial Recruitment And Why It Can't Wait
1/14/2026
Alzheimer's trials face urgent recruitment challenges. Data-driven strategies, digital tools, and community engagement can accelerate enrollment and improve retention in this complex therapeutic space.
-
Quantifying Potential: Leveraging Data To Showcase Biotech Value
1/14/2026
Biotechs must use data-driven insights to prove asset potential. Real-world evidence and predictive analytics validate differentiation, forecast market opportunity, and build investor confidence.
-
Designing The Path: Strategic Planning To Maximize Biotech Appeal
1/14/2026
Aligning clinical, regulatory, and operational strategies boosts biotech investment appeal. Strategic planning, clear milestones, and risk mitigation accelerate development and attract funding.
-
Crafting The Vision: Building A Strong Value Story For Biotechs
1/14/2026
Early-stage biotechs need more than science — they need a clear vision. Learn to craft a value story that shows differentiation, market potential, and patient impact to attract investors and partners.